Rock Edwin
SEC CIK 1945417 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CBIO | CRESCENT BIOPHARMA, INC. | Chief Medical Off | 680.4K | $725.3K | — | 4 | 2022-11-14 | 2024-06-20 |
Most active insiders at CBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Harwin Peter Evan | Dir, 10% | $18.24M | — |
| 2 | Fairmount Funds Management LLC | Dir, 10% | $12.38M | — |
| 3 | Brumm Joshua T | CEO, Dir | — | $920.8K |
| 4 | McNeill Jonathan | Pres, COO | — | $446.9K |
| 5 | Pinkas Jan | CSO | — | $34.9K |
| 6 | Im Ellie Eunkyung | Chief Medical Off | — | $33.1K |
| 7 | Bispham Barbara Harlin | See Remarks | — | $33.0K |
| 8 | Scalzo Richard William | CFO | — | $30.2K |
| 9 | Lynch Ryan | See Remarks | — | $12.7K |
| 10 | Doughty Christopher Grant | Chief Business Off | — | — |
Rock Edwin made no open-market trades at CBIO in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-24 | 2024-06-20+ | CBIO | CRESCENT BIOPHARMA, INC. | Rock Edwin | Chief Medical Off | P - Purchase | $0.2575 | +305.0K | 680.4K | +81% | +$78.5K |
| M | 2023-09-25 | 2023-09-21+ | CBIO | CRESCENT BIOPHARMA, INC. | Rock Edwin | Chief Medical Off | P - Purchase | $1.38 | +65.4K | 345.0K | +23% | +$90.3K |
| 2022-12-27 | 2022-12-22 | CBIO | CRESCENT BIOPHARMA, INC. | Rock Edwin | Chief Medical Off | P - Purchase | $2.25 | +110.0K | 310.0K | +55% | +$247.5K | |
| M | 2022-11-16 | 2022-11-14+ | CBIO | CRESCENT BIOPHARMA, INC. | Rock Edwin | Chief Medical Off | P - Purchase | $1.54 | +200.0K | 200.0K | New | +$309.0K |
Purchase Sale Sale after option exercise All abbreviations